About this trial
This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 18 to 70 years old.
Both sexes.
Septic patients (under the third international consensus definitions of sepsis and septic shock).
Disqualifiers
Pregnancy
Malignancy
On immunosuppressive therapy
Hematological Disorders
Trial population
A prospective observational study will be conducted at Ain Shams University Hospital, Cairo, Egypt.
Trial design
Cohort
Prospective
Treatments tested in this trial
Neutrophils to Lymphocytes and Platelets ratio (N/LP)
Diagnostic testThe Neutrophils to Lymphocytes and Platelets ratio (N/LP) will be measured
Treatment groups
Trial outcomes
Primary outcomes
Levels of Neutrophils to Lymphocytes and Platelets ratio
The ratio of neutrophils to Lymphocytes and Platelets in relation to 28-day mortality among septic patients will be recorded.
Secondary outcomes
Procalcitonin (PCT)
Procalcitonin (PCT) in relation to 28day mortality among septic patients will be recorded.
Total Leukocytic Count (TLC)
Total Leukocytic Count (TLC) in relation to 28day mortality among septic patients will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.